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http://dx.doi.org/10.1016/j.stemcr.2016.04.006SUMMARYTension production and contractile properties are poorly characterized aspects of excitation-contraction coupling of human induced
pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Previous approaches have been limited due to the small size and structural
immaturity of early-stage hiPSC-CMs. We developed a substrate nanopatterning approach to produce hiPSC-CMs in culture with adult-
like dimensions, T-tubule-like structures, and alignedmyofibrils. We then isolatedmyofibrils from hiPSC-CMs andmeasured the tension
and kinetics of activation and relaxation using a custom-built apparatus with fast solution switching. The contractile properties and ul-
trastructure of myofibrils more closely resembled human fetal myofibrils of similar gestational age than adult preparations. We also
demonstrated the ability to study the development of contractile dysfunction of myofibrils from a patient-derived hiPSC-CM cell line
carrying the familial cardiomyopathyMYH7mutation (E848G). These methods can bring new insights to understanding cardiomyocyte
maturation and developmental mechanical dysfunction of hiPSC-CMs with cardiomyopathic mutations.INTRODUCTION
Methods to mature human induced pluripotent stem cell-
derived cardiomyocytes (hiPSC-CMs) may provide consid-
erable advantages to model inherited cardiac diseases in
culture (Eschenhagen et al., 2015; Jung and Bernstein,
2014; Yang et al., 2014a). Early-stage hiPSC-CMs lack
discernible T tubules, display rhythmic spontaneous
beating with short action potential duration and slow,
diffusion-limited calcium influx (Lundy et al., 2013). In
addition, the contractile machinery of hiPSC-CMs is typi-
cally sparse and poorly organized (Gherghiceanu et al.,
2011; Kamakura et al., 2013; Lundy et al., 2013).Measuring
tension remains one of the least characterized aspects of
excitation-contraction coupling (ECC), due to the small
size and structural immaturity of hiPSC-CMs. Thus, devel-
oping methods to measure the contractile properties of
hiPSC-CMs and their subcellular organelles, myofibrils,
could improve our knowledge of how early-stage cardio-
myocytes function during fetal development and at the
earliest stages of heart disease.
In multicellular preparations, such as engineered heart
tissue constructs, contractile tension of hiPSC-CMs prop-
agates from cell to cell, and tension generation is in theStem
This is an open access article under the Corder of micronewtons/section (Tulloch et al., 2011).
However, low cell density, sparse cell-cell coupling, and
the compliance of hydrogel- or protein-based scaffolds
likely underestimates tension generation and affect con-
tractile kinetics measurements. Single hiPSC-CM tension
has been estimated by contraction stress assays (Ribeiro
et al., 2015) or atomic force microscopy (Liu et al.,
2012; Sun et al., 2012) but at dissimilar post-differentia-
tion times. Moreover, two-point force assays detect
twitch properties along a single axis and do not include
lateral stresses, including friction due to the culture sur-
face. Individual cardiomyocytes cultured on micropost
arrays (Rodriguez et al., 2011, 2014; Yang et al., 2014b)
can obviate this gap by measuring the tension, velocity,
and power of contraction for subcellular bundles of
myofibrils at each adhesion point. However, culturing
hiPSC-CMs on micropost arrays limits myofibril elonga-
tion and bundling, cell morphology maintains a high
circularity index, and the resultant tension is the sum
of the contraction of unaligned myofibrils developed in
multiple directions.
Myofibrils are the smallest subunit of the cardiomyocyte
contractile apparatus and consist of sarcomeres (single
contractile units) in series. Here we present a method toCell Reports j Vol. 6 j 885–896 j June 14, 2016 j ª 2016 The Authors. 885
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Protocol for Cardiac Maturation of Human Pluripotent Stem Cells on Nanopatterned Surfaces in Long-Term Cultures
(A–E) Phase-contrast images of hiPSCs at different stages of differentiation and cardiac maturation. (A) hiPSC passaging before differ-
entiation. (B) At day 0, hiPSCs were differentiated into cardiomyocytes with a monolayer-directed differentiation protocol. Beating areas
were visible from day 8 post-differentiation (p.d.). (C) At 15 p.d, single hiPSC-CMs were replated onto nanopatterned surfaces until day
80–100 in low density for cardiac maturation. Early-stage hiPSC-CMs were round-shaped and lacked of aligned myofibrils. (D) After re-
plating, hiPSC-CMs showed early progressive elongation and increased myofibril density/alignment. (E) Later-stage hiPSC-CMs were
rod-shaped and myofibrils were highly aligned. These cells had length of 127.3 ± 8.8 mm and width of 14.7 ± 0.9 mm (n = 44 from controls).
Scale bars in (A) and (B) represent 200 mm; scale bars in (C), (D), and (E) represent 20 mm.measure the mechanical properties of single myofibrils iso-
lated from hiPSC-CMs by a fast solution switching method
(Colomo et al., 1998) that represents a unique tool to assess
both steady-state tension and kinetics of contraction and
relaxation, independent of the Ca2+ handling properties
of the cells. The biochemicalmilieu surroundingmyofibrils
can easily be controlled experimentally to provide mecha-
nistic insights on actin-myosin cross-bridge cycling and
regulation of tension development and relaxation kinetics.
Mechanical properties of myofibrils from hiPSC-CMs have
not previously been investigated due to their small size and
fragility in culture. To overcome this limitation, we devel-
oped strategies to drive cardiomyocytemorphology toward
an adult phenotype. Single cardiac cells were seeded at low
density onto nanopatterned surfaces (Kim et al., 2010;
Macadangdang et al., 2014, 2015) and cultured long term
(Lundy et al., 2013). This resulted in cell elongation and
myofibril bundling, demonstrated by Z bands across the
entire cell width and length. Cells had increased myofibril
density with evidence of T-tubule formation. We then iso-
lated hiPSC-CM functional myofibrils from nanopatterned
cultures to study their contractile properties. We used this
system to compare hiPSC-CM myofibrils with those from
fetal and adult hearts and to demonstrate impaired myofi-
bril mechanics from a patient-derived line harboring a
cardiomyopathic mutation (E848G) in b-myosin heavy
chain (MYH7).886 Stem Cell Reports j Vol. 6 j 885–896 j June 14, 2016RESULTS
Engineering hiPSC-CM Morphology
hiPSC-CMs were generated from cells collected either from
urine (control1) (Guan et al., 2014) or skin fibroblasts
(control2; FCM) using directed differentiation of high-den-
sity monolayers with a combination of activin A and
BMP4, along with small molecules that sequentially acti-
vate and repress Wnt/b-catenin signaling (Palpant et al.,
2015) (Figures 1A and 1B). At 15–20 days post-differentia-
tion (p.d.), single hiPSC-CMs were replated at low density
onto fibronectin-coated nanopatterned surfaces fabricated
with parallel grooves and ridges of 800 nm width and
spacing to promote cell spreading (Kim et al., 2010). Just
after replating, 15–20 days p.d. hiPSC-CMs were round-
shaped and demonstrated sporadic signs ofmyofibrillogen-
esis with sparse expression of sarcomeric elements and
assembly in fieri (Figures 1C and 5A, top). Obtaining me-
chanical measurements from these pre-myofibrils is quite
challenging due to their short length and fragility. There-
fore, to achieve myofibril lengths (>50+ mm) and stability
that would enable us to obtain mechanical measurements
on our experimental platform, hiPSC-CMs were cultured
for an additional 60 days on nanopatterned surfaces
(80–100 days p.d. total). This resulted in cells that
were elongated (Figure 1D), and many had dimensions
similar to those found for cultured adult cardiomyocytes
Figure 2. Later-StagehiPSC-CMsGrownon
a Nanopatterned Surface Promote Myofi-
bril Alignment and T-Tubule Formation
(A) Confocal images of later-stage hiPSC-
CMs grown on nanopatterned surfaces. Cells
were stained for Z bands (a-actinin, red)
and for nuclei (DAPI, blue). hiPSC-CMs ex-
hibited mature morphology with rod-sha-
ped, aligned myofibrils and clearly defined
Z bands (enlargement of the area within
the white rectangle) as quantified by fast
Fourier transform (FFT) analysis.
(B) Confocal images of hiPSC-CMs stained
with antibody against caveolin-3 (green),
a actinin (red), and nuclei (blue). Top:
hiPSC-CMs displayed development of a
transverse-axial tubular system (TATS),
with both transverse and axial elements.
Bottom: representative 3D picture of TATS
in hiPSC-CMs. Arrowheads in the 3D recon-
struction highlight transverse tubular ele-
ments (green), running in parallel to a Z line
(red). Axial tubules occurred perpendicu-
larly to the Z lines and were evident in the
side view. Scale bars represent 20 mm.(Figure 1E). Cells were rod-shaped with average lengths of
127.3 ± 8.8 mm and average widths of 14.7 ± 0.9 mm. In
all hiPSC-CMs, myofibril alignment followed the nanoto-
pographic pattern.
Adult-likeMorphology and Dimensions of Later-Stage
hiPSC-CMs
Later-stage hiPSC-CMs (80–100 days p.d. total; Figure 1E)
were stained for Z bands (anti a-actinin). As observed by
phase-contrast imaging (Figure 2A), quantitative immuno-
cytochemical analysis demonstrated later-stage control-
hiPSC-CMs were characterized by aligned myofibrils and
clearly defined Z bands spanning the width of the cells.
We used fast Fourier transform analysis to quantify
the myofibril alignment index based on the regularity of
Z bands. Later-stage hiPSC-CMs (Figure 2) had an extended
cell area (control = 7,696 ± 519 mm2) and perimeter (con-
trol = 291 ± 11 mm) with an elevated index of myofibril
alignment (control = 0.014 ± 0.002), indicating a high
impact on myofibril organization with this combinatorial
approach for cardiomyocyte maturation.
We further investigated the cell structure by staining for
caveolin-3 (CAV3), a scaffolding protein of the sarco-
lemma, which is associated with the formation of caveolae
and T tubules during the development of striated muscle
(Parton et al., 1997). CAV3 is also implicated in several elec-
tromechanical regulation pathways (Gazzerro et al., 2010).
Top and side views of confocal images (Figure 2B) display
the organization of cells co-stained for CAV3 and Z bands.In a 3D reconstruction of the confocal images, the cells had
a homogeneous distribution of CAV3 over the entire sarco-
lemma. CAV3 staining revealed finger-like invaginations
tightly associated with Z bands, likely representing trans-
verse (T)-tubule-like structures during development (Pasek
et al., 2008). This finding provides evidence that trans-
verse-axial tubular system (TATS) formation may occur
together withmyofibrillogenesis and suggests a strict inter-
play between tubules and Z bands during cardiac develop-
ment on nanopatterned surfaces.
Isolation of Myofibrils from hiPSC-CMs
The improved cell morphology and size of later-stage cardi-
omyocytes cultured on nanopatterned surfaces allowed us
to obtain isolated myofibrils with sufficient length and sta-
bility for detailed contractile analysis. To isolate myofibrils,
wemodified a procedurewehave commonly used to obtain
myofibrils from cardiac tissue. This method is demon-
strated in Figure 3A. We examined two cell skinning ap-
proaches to harvest myofibrils: (1) cultured hiPSC-CMs
were subjected to pre-treatment with a Rho-associated
protein kinase inhibitor (ROCKi) for 1 hr to promote cell
detachment and prevent the anoikis phenomena. Cells
were subsequently detached by treatment with Versene
for 1 hr. hiPSC-CMs were collected from the supernatant
and rapidly skinned in rigor solution containing Triton
X-100 buffer (1%) for 10 min (skinning in suspension; Fig-
ure 3A (1)). Triton X-100 was then removed by two sequen-
tial rinses in normal rigor solution. Versene treatment isStem Cell Reports j Vol. 6 j 885–896 j June 14, 2016 887
Figure 3. Isolation, Tension Generation, and Kinetic Properties of hiPSC-CM Myofibrils
(A) Scheme for the isolation of myofibrils from hiPSC-CMs. Two skinning approaches were developed. (1) Skinning in suspension: myofibril
density in the final suspension was variable and limited by the efficiency of cell detachment. (2) Skinning on plate: myofibril density in the
final suspension was significantly higher. Right: representative phase-contrast images of a thin bundle of myofibrils from hiPSC-CMs,
collected with the latter method at different magnifications. Myofibrils were mounted between the tip of a length controller (left) and a
calibrated cantilever (right) in a custom-built apparatus. Myofibril mechanics and kinetics were measured by fast solution switching.
(B) Representative traces of tension generation of hiPSC-CM (blue), human ventricular fetal (fetal, gray) and adult (black) myofibrils
maximally activated. Compared with adult, both fetal and hiPSC-CM myofibril isometric maximal tension (pCa 4.0) was weaker.
(C) Dashed line represents the line fit to the data (N > 3 and n = 4–40 per condition) from Racca et al. (2015) of how tension-generating
capacity developed with increasing gestational age of human fetal ventricular samples (Racca et al., 2015). hiPSC-CM (80 days p.d., blue)
myofibrils generated the same maximal tension as those of human fetal ventricle at a similar gestational age (74 days gestation, gray).
(D) Following Ca2+ application, force developed exponentially with a rate constant (kACT) that reflects the cross-bridge turnover rate. In
hiPSC-CM myofibrils, kinetics of activation were in the same order of magnitude. Data from human fetal and adult cardiac myofibrils are
reported in Racca et al. (2015). Experimental conditions: 15C; pCa relaxing and activating solution, 9.0 and 4.0, respectively.gentle and helps to retain intact cell architecture
throughout the skinning process. The limiting aspect of
this approach is the efficiency of cell detachment, which
can affect myofibril density in the final suspension. (2)
The second approach consisted of skinning hiPSC-CMs in
rigor solution with 1% Triton X-100 applied directly on
culture plates for 5 min (skinning on plate; Figure 3A (2)).
The quality of viable myofibrils obtained with the two
approaches was indistinguishable, as determined by the
morphological and contractile properties, however the888 Stem Cell Reports j Vol. 6 j 885–896 j June 14, 2016yield of myofibrils was substantially greater with the sec-
ond approach. Thus, we used the second method to obtain
isolated single and small bundles of myofibrils (Figure 3A
right) to assess the contractile properties of all hiPSC-CM
lines.
Mechanical and Kinetic Properties of Myofibrils from
hiPSC-CMs
Figures 3B and 4A illustrate representative tension traces of
myofibrils from later-stage hiPSC-CMsmaximally activated
Figure 4. Tension Generation and Kinetic Properties of Control and FCM-hiPSC-CM Myofibrils
(A) Representative traces of tension generation of control (blue) and FCM-CM (red) myofibrils maximally activated and fully relaxed by the
fast solution switching method.
(B) Compared with controls, FCM-CMs myofibril isometric maximal tension (pCa 4.0) is impaired. At submaximal Ca2+ level (pCa 5.8),
tension generation was reduced 50% in control but only 28% in FCM, indicating increased Ca2+ sensitivity of tension development (N > 3
and n = 15–26 per condition).
(C) Left: following Ca2+ application, tension develops exponentially with a rate constant (kACT). Right: the reversed movement of the
pipette induced biphasic relaxation. In the slow linear phase (rate, slow kREL and duration slow tREL), force decay occurred under isometric
conditions and in the absence of Ca2+. The fast exponential phase (rate, fast kREL) follows sarcomere ‘‘give’’ and reflects inter-sarcomere
dynamics. FCM-CM myofibrils exhibited faster kACT, indicating an accelerated cross-bridge turnover rate. Slow kREL was faster with no
difference in slow tREL. The fast monoexponential phase of relaxation (fast kREL) was slower.
Averages in (B) are reported as means ± SEM; data shown refer to Table 1; **p < 0.01; NS not significant estimated by Student’s t test.(15C) by rapid solution switching, via a double-barreled
perfusion pipette, from low Ca2+ (pCa9) to high Ca2+
(pCa4) (Racca et al., 2015). With activation, tension devel-
oped exponentially with a rate constant (kACT; Figures 3D
and 4C) that reflects thin filament activation upon Ca2+
binding, the rate of strong myosin binding to actin (cross-
bridge formation), the subsequent force-generating cross-
bridge isomerization and initial cross-bridge turnover. The
inverse movement of the perfusion pipette results in rapid
Ca2+ removal from the solution flow, subsequently result-
ing in an initial slow, linear phase of relaxation followedby rapid relaxation to baseline tension. During the slow
phase of relaxation, force decay occurs under isometric
conditions with a rate constant (slow kREL; Figure 4C) re-
flecting the rate of cross-bridge detachment, independent
of Ca2+ dissociation from troponin C. The subsequent fast
monoexponential phase of relaxation (fast kREL; Figures
4A and 4C) is associated with sarcomere ‘‘give’’ and reflects
inter-sarcomere dynamics (Poggesi et al., 2005). Maximal
and submaximal (pCa5.8) isometric tension and the
kinetic properties of myofibrils from hiPSC-CM cell lines
were obtained from two healthy adults. Control1- andStem Cell Reports j Vol. 6 j 885–896 j June 14, 2016 889
Table 1. Summary of Mechanical and Kinetic Properties of Myofibrils From hiPSC-CMs Following Maximal and Submaximal Ca2+
Activation
Myofibril Typea Tension (mN/mm2)b kACT (s
1)c kREL, Slow (s
1)d tREL, Slow (ms)
e kREL, Fast (s
1)f
pCa 4.0g
Control (n) 18.6 ± 2.5 (26) 0.51 ± 0.04 (23) 0.30 ± 0.04 (25) 192 ± 7.4 (29) 2.66 ± 0.3 (25)
FCM (n) 8.2 ± 1.4 (15)** 0.83 ± 0.13 (14)* 0.37 ± 0.09 (13) 191 ± 21 (13) 1.69 ± 0.3 (15)*
pCa 5.8h
Control (n) 8.5 ± 1.4 (22) 0.39 ± 0.06 (22) 0.30 ± 0.03 (17) 154 ± 7.9 (21) 2.47 ± 0.4 (22)
FCM (n) 5.9 ± 1.3 (14) 0.40 ± 0.04 (13) 0.58 ± 0.12 (15)* 186 ± 17 (14) 2.07 ± 0.4 (15)
*p < 0.05; **p < 0.01; estimated by Student’s t test.
aData are means ± SEM. For the comparison with FCM myofibrils, control1 and control2 data were merged. N = 3 for each condition.
bTension, maximal, and submaximal Ca2+-activated tension.
cRate of force generation following Ca2+-activation.
dSlow, rate of the slow isometric phase of relaxation estimated from the normalized slope of the linear fit to the force trace.
eSlow, duration of the slow isometric phase of relaxation following sudden Ca2+ removal.
fFast, rate of the fast phase of relaxation estimated from the time constant of the exponential fit to the force trace.
gMaximal activating solution.
hSubmaximal activating solution.control2-hiPSC-CMswere highly comparable in themagni-
tude anddevelopment ofmaximal tension (kACT, pCa4) and
relaxation parameters (slow kREL, slow tREL, and fast kREL)
(Table S1). Thus, we merged the two datasets for all subse-
quent comparisons (Table 1).
In order to characterizemyofibril mechanics and kinetics
from hiPSC-CMs, we sought to compare these contractile
properties with similar measurements from human fetal
and adult cardiac myofibrils, reported recently by our
group (Belus et al., 2010; Piroddi et al., 2007; Racca et al.,
2015). Figure 3C shows representative tension traces from
hiPSC-CMs versus fetal (74 days gestational) and adult
myofibrils. Isometric tension generation of hiPSC-CM
myofibrils was about 6-fold less than adult human ventric-
ular (Piroddi et al., 2007) or atrial myofibrils (Belus et al.,
2010), and about 5-fold less compared with failing human
myocardium (Moussavi-Harami et al., 2015; Racca et al.,
2015). However, myofibril tension was comparable with
our recent report on human fetal ventricular myocardium
of a similar age (Racca et al., 2015). Figures 3B and 3C shows
that later-stage hiPSC-CM tension (80 days p.d.) closely
matches age-related progression of increasing tension of
human cardiac tissue in utero. In contrast to tension pro-
duction, the kinetics of activation and relaxation for
hiPSC-CM myofibrils was similar to what we have previ-
ously reported for adult and fetal myofibrils (Figure 3D),
indicating related acto-myosin kinetics at this stage. This
may be primarily due to all three myofibril groups having
b-MHC as the predominant contractile motor isoform
(see below). Thus, our data indicate that the magnitude
of myofibril tension production is a more valid yardstick890 Stem Cell Reports j Vol. 6 j 885–896 j June 14, 2016for estimating maturation of cardiac myofibrils than pa-
rameters of activation and relaxation kinetics. In addition,
even though later-stage hiPSC-CMs are beginning to
resemble adult cardiomyocyte morphology, our data indi-
cate that the maturation state of individual myofibrils
more closelymatches gestational development of fetal ven-
tricular muscle.
Modeling Development of Contractile Dysfunction
with Familial Cardiomyopathy Mutations
To test the feasibility of using hiPSC-CMs to study the
development of contractile abnormalities for disease-asso-
ciated mutations in sarcomere proteins, we compared
age-matched FCM-hiPSC-CMs (FCM) carrying the muta-
tion E848G in b-MHC differentiated and cultured under
the same conditions as controls (control-CMs). FCM-
hiPSCs were generated from a family showing a unique fa-
milial cardiomyopathy that appeared with relatively early
onset of arrhythmias, systolic and diastolic dysfunction,
without changes in chamber size andwall/septal thickness,
suggesting a non-hypertrophic phenotype. Compared
with control-CMs, FCMs had increased cell area (p < 0.01)
and cell perimeter (p < 0.05) (Figure S1). Fast Fourier trans-
form quantitative analysis of the FCMmyofibril alignment
index indicated myofibril disarray throughout the cyto-
plasm of some but not all FCMs, compared with consistent
control-CM myofibril alignment, presenting a puzzling
variability for the FCM cells (p < 0.01). Despite this
dramatic difference in myofibril organization, resting
sarcomere length (the distance between Z bands within a
myofibril) was comparable with control-CMs (p = 0.71).
Figure 5. Ultrastructural Organization
and Proteomics of Later-Stage hiPSC-
CMs on Nanopatterned Surfaces Reveal
Immature Sarcomeric Composition
Single cells in sparse cultures on nano-
patterned surfaces were investigated for
sarcomeric ultrastructures.
(A) Transmission electron microscopy (TEM)
images of early-stage (control1), later-
stage (control1), and FCM-hiPSC-CMs (FCM-
CMs) at low magnification (12,0003) show
the presence of aligned myofibrils. Early
stages look quite immature with contractile
machinery forming but early occurrence of
myofibril alignment. Later stages (both
control and FCM-CMs) were more mature
showing bundling of Z bands (arrowheads).
(B) TEM images acquired at higher magnifi-
cation (40,0003) confirm a clear alignment
of Z disks (arrowheads), but variable-spaced
thick filaments remarkably visible in FCM-
hiPSC-CMs with evidence of myofibril
disarray in some cases. Both later-stage cell
lines expressed I-Z-I bands with no clear
evidence of H zones. In FCM-CMs, the sar-
comeric ultrastructure was highly variable
with sparse expression of M lines (stars).
(C) Proteomics of later-stage hiPSC-CMs
(100 days p.d.) were compared with fetal
left ventricular (LV) samples (130 gestational days). b-myosin was predominant at this stage of maturation indicating a to b isoform
switch has occurred. CTNI expression indicated a higher grade of maturation. However, SSTNI was still expressed, confirming immature
phenotype as seen for fetal LV. Representative western blot images were cropped. Scale bars represent 1 mm for the overview and 500 nm
for the detailed view.In addition, the CAV3 expression profile was similar for
both cell lines with analogous distribution throughout
the sarcolemma (Figure S2).
Representative traces (Figure 4A) demonstrate marked
impairment of maximal isometric tension generation for
FCM myofibrils (p < 0.01; Figure 4B and Table 1). We also
measured tension at a submaximal Ca2+ level (pCa 5.8),
closer to where the heart operates. At pCa 5.8, tension gen-
eration was approximately half maximal for control-CM
myofibrils, but about 0.72 of maximal tension for FCM
myofibrils (Figure 4B and Table 1). This suggests that
FCM myofibrils had increased Ca2+ sensitivity of tension
development (Figure 4B), as reported for other hypertro-
phic cardiomyopathy mutations (Poggesi and Ho, 2014).
During maximal activation, kACT was faster (p < 0.05) for
FCM myofibrils (Figure 4C and Table 1), suggesting an
increased rate of acto-myosin cross-bridge turnover. As ex-
pected, at submaximal Ca2+ levels, kACTwas slower than for
maximal (pCa 4.0) activations (Table 1). However, in
contrast to maximal kACT (Figure 4C and Table 1), there
was no difference in kACT at pCa5.8 (p = 0.83). There were
also differences in the relaxation kinetic parameters. SlowkREL (Figure 4C and Table 1) was faster for FCM myofibrils
but the differencewas significant only for submaximal acti-
vation (pCa4.0, p = 0.25; pCa5.8, p < 0.05), a finding that
supports the hypothesis that the cross-bridge detachment
rate is increased (Figure 4C and Table 1). The cross-bridge
detachment rate is one determinant of the cross-bridge
turnover rate, suggesting that the E848G b-MHCmutation
may increase cross-bridge turnover by accelerating cross-
bridge detachment. This could at least partially explain
the lower tension-generating capacity of FCM myofibrils.
Finally, there was also a difference in fast kREL, which
was slower for FCM myofibrils during maximal activation
(p < 0.05). This may be a consequence of the increased
myofibril Ca2+ sensitivity (Kreutziger et al., 2011; Stehle
et al., 2009).
Myofibril Ultrastructural and Proteomics
Longitudinal sections of single hiPSC-CMs sparsely
cultured onto nanopatterned surfaces were analyzed by
transmission electron microscopy (TEM). Images of con-
trol- and FCM-CMs clearly demonstrate myofibril align-
ment (Figure 5A), previously based on Z-band stainingStem Cell Reports j Vol. 6 j 885–896 j June 14, 2016 891
(Figures 2A and S1). Although morphological analysis by
confocal images may suggest adult-like cell characteristics,
the ultrastructural architecture of myofibrils demonstrated
variable-spaced thick filaments that frequently had a
paucity of sarcomeric determinants. Both cell lines ex-
pressed I-Z-I bands, although no evidence of H zones was
identified (Figure 5B). In FCM-CMs, the variable phenotype
of the sarcomeric ultrastructure appeared more pro-
nounced within cells, with sparse expression of M lines
(Figure 5B).
Western blot analysis of myosin isoform composition
indicated a significant amount of b-MHCpresent in control
and FCM myofibrils, suggesting that the myosin isoform
switch likely began prior to this stage of maturation (Fig-
ure 5B). This agrees well with our recent report that fetal
cardiac myofibrils contain b-myosin predominantly as
early as 74 days gestation (Racca et al., 2015), which, in
turn, agrees with reports by others (Reiser et al., 2001).
These data also suggest that differences in contractile ki-
netics between control and FCM myofibrils were not the
result of the myosin isoform, suggesting that they were
likely due to the E848G mutation. Troponin I (TNI) iso-
forms can be used as an indicator of maturation. Early in
development, cardiomyocytes express slow skeletal TnI
(SSTNI). As maturation proceeds, the cardiac isoform of
TNI begins to be expressed and later in development be-
comes the predominant isoform (Racca et al., 2015; Sasse
et al., 1993). Control- and FCM-CMs expressed both TNI
isoforms (Figure 5C) indicating that the maturation state
of the myofibrils was more similar to fetal left ventricular
myofibrils than adult (which express CTNI exclusively),
consistent with other hiPSC-CMs cultured over time
(Bedada et al., 2014).DISCUSSION
In this study, we report that hiPSC-CMs on nanogrooved
surfaces in long-term culture can achieve a high degree of
structural maturation. Previous reports concluded that T
tubules in 2D culture are nearly absent in hiPSC-CMs
(Jung and Bernstein, 2014; Yang et al., 2014a). Here,
hiPSC-CMs demonstrated clear evidence of a complex ar-
chitecture that may be associated with forming TATS, and
this should be further explored (Sacconi et al., 2012).
TATS is an important hallmark for ECC regulation, with
well-aligned Z bands together with composition of elon-
gated myofibrils. We isolated functional myofibrils from
these later-stage hiPSC-CMs using a cell skinning method
and used a custom-built apparatus (Kreutziger et al.,
2011; Racca et al., 2015) to measure maximal and submax-
imal myofibril tension generation that was considerably
greater than values from previous reports in intact hiPSC-892 Stem Cell Reports j Vol. 6 j 885–896 j June 14, 2016CMs (Ribeiro et al., 2015; Rodriguez et al., 2014; Sun
et al., 2012). Our values demonstrate weaker force
compared with adult cardiac myofibrils but, interestingly,
very similar to what we recently reported for human fetal
myofibrils of similar gestational age (Racca et al., 2015).
Thus, the morphological maturation of later-stage hiPSC-
CMs was not matched by maturation of myofibril contrac-
tile properties, suggesting that caution should be used
when reporting the maturation state by limited analytical
criteria.
This study represents a solid step forward in the study of
hiPSC-CM development, and it further demonstrates its
utility to model the development of disease-related cardio-
myocyte contractile dysfunction. First, we may have estab-
lished features of in vivo gestational maturation in an
in vitro model, as indicated from our comparisons with
fetal cardiac myofibrils. Second, we may now consider
myofibril tension and kinetics of contraction and relaxa-
tion as parameters to quantitatively assess maturation state
of hiPSC-CM contractile machinery. Others have reported
high similarities between hiPSC-CMs and human fetal car-
diomyocytes in the gene expression profile (Kuppusamy
et al., 2015; Synnergren et al., 2012; van den Berg et al.,
2015), structural composition (Gherghiceanu et al., 2011;
Kamakura et al., 2013; Lundy et al., 2013), and electrophys-
iological and contractile properties (Ribeiro et al., 2015).
However, to our knowledge, no other study has quantified
the maturation stage of hiPSC-CMs in comparison with
fetal cardiomyocyte development. We observed ultrastruc-
tural features of sarcomeric units in fieri in which embry-
onic protein isoforms are still expressed (more SSTNI
than CTNI), which may partially explain why the contrac-
tile properties resemble those of fetal myofibrils. Sarcomere
structural and functional determinants reflected those
recently observed in fetal myocardium (Racca et al., 2015)
and other (more)-mature hiPSC-CM cell lines (Lundy
et al., 2013) rather than adult ventricular myofibrils (Belus
et al., 2010; Racca et al., 2015). Expression of the b-MHC
isoform at this stage of maturation explained the simi-
larities in kinetic parameters and that the switch from the
a- to b-MHC isoform seen very early in human ventricular
myocardial development has already occurred (Racca et al.,
2015; Reiser et al., 2001). Moreover, later-stage hiPSC-CMs
had cross-bridge kineticsmore representative of ventricular
versus atrial myofibrils (Belus et al., 2010; Piroddi et al.,
2007), where the rate of cross-bridge turnover is faster
due to the presence of a-myosin heavy chain (MYH6
gene). Since the kinetics are similar between myofibrils
from hiPSC-CMs and fetal and adult human ventricle mus-
cle, this suggests that in addition to b-myosin, the light
chains may also have changed to the ventricular forms.
Future studies to test this hypothesis could include an in-
depth analysis of myosin light chain isoform composition,
in parallel with heavy chain isoform analysis, as MLC-2v
and -2a have been previously proposed as markers for ven-
tricular and atrial differentiation, respectively (Bedada
et al., 2014). This may suggest that hiPSC-CMs matured
in our conditions developmyofibrils that favor the ventric-
ular rather than the atrial contractile phenotype (Bedada
et al., 2014). Thus, myofibril mechanics and kinetic proper-
tiesmay be useful for evaluating the composition of cardiac
ventricular versus atrial populations following differentia-
tion, while myofibril contractile properties and sarcomere
protein composition may be used as a yardstick for func-
tional maturation that has previously been based primarily
on action potential profiles. Our results also point to a note
of caution. Despite a misleading adult-like morphology
observed by confocal microscopy, the hiPSC-CMs in our
study should be considered more as fetal cardiomyocytes
in their fine structure and functional capacity, and not be
considered as recapitulating the adult cardiomyocyte
phenotype.
Since hiPSC-CMs canmature in vitro over time in culture
(Lundy et al., 2013), they may prove valuable for investi-
gating the developmental time course of early-stage cardiac
diseases, representing a unique platform to predict adverse
prenatal outcomes and to develop therapies. We reported
FCM hiPSC-CMs carrying the E848G- b-MHC mutation
had similar maturation in terms of T-tubule formation
but abnormalities at the myofibril level. Myofibril disarray
has been described for other MYH7 mutations and can
result from variable expression of mutated and wild-type
myosin in individual myocytes, as previously proposed
(Kraft et al., 2013). Force decrements result from several
MYH7 mutations (Witjas-Paalberends et al., 2013) and
could be due to cardiomyocyte and/or myofibril disarray.
Here we demonstrated that, at the individual myofibril
level, there is also a force deficit with the E848G b-MHC
mutation, which in addition to likely myofibril structural
alterations, may be partially due to an accelerated cross-
bridge detachment. A pathway similar to the latter was pre-
viously suggested for myofibrils from one patient carrying
the R403Q b-MHC mutation associated with hypertrophic
cardiomyopathy (HCM) (Belus et al., 2008). For the R403Q
mutation, an increased cross-bridge detachment rate was
related to an increased cost of tension generation (Witjas-
Paalberends et al., 2014) and reduced force-generating
capacity (Ferrantini et al., 2009). In addition, the develop-
ment of the sarcomere structure may be delayed or altered
during maturation by disease-associated mutations.
Notably, increased Ca2+ sensitivity and altered cross-
bridge kinetics have been reported as hallmarks of human
adultmyocardium expressing severalMYH7mutations (Be-
lus et al., 2008; Witjas-Paalberends et al., 2014). However,
in the FCM cell line, structural variability may lead to
different amounts of b-myosin heavy chain (and/or totalmyosin) incorporated into forming myofibrils during
maturation, contributing to additional contractile deficits.
As a feedback mechanism, weaker tension-generating
myofibrils during mechanical loading may lead to cellular
hypertrophy during development. We were limited in our
ability to quantify sarcomere protein content and concen-
tration in this study, due to the limited amount of the
frozen remains of the same myofibril preparations used
for the mechanical experiments. Future studies will focus
more on documenting the absolute amount of troponin
or the relative abundance of SSTNI versus CTNI, as this
may affectmyofibril Ca2+ sensitivity and troponin complex
activation (Kreutziger et al., 2011), even if the kinetics of
force development or relaxation may be not influenced
by the TnI isoform switch (de Tombe et al., 2007).
In conclusion, we were able to assess the structure and
function of myofibrils from hiPSC-CMs at a relatively
advanced state of maturation, and compared them with
properties previously reported for myofibrils from human
fetal ventricular muscle. That said, much work remains to
be done. We report on only a single time point, thus have
not established a developmental time course. In addition,
it would be interesting to see if maturation could be further
progressed with a longer time in culture or via application
of biological molecules such as T3, Let-7 (Kuppusamy et al.,
2015; Yang et al., 2014b), or other transcriptional and
maturation regulators, or with other environmental condi-
tions such as electrical stimulation and/or varying load.
Future studies should also provide more complete and
detailed proteomic information regarding the time course
of protein isoform appearance, disappearance, stoichiom-
etry of proteins incorporated into myofibrils and post-
translational modifications. We have also demonstrated
the utility of this approach to study the influence of dis-
ease-associated mutations on myofibril structure and func-
tion. However, this is just one example of the potential of
the approach that can not only be compared with normal
development, but also with a myriad of other disease-asso-
ciated mutations. Finally, while we have provided initial
evidence that T-tubule formation may be initiated under
our conditions, future studies are needed to verify and
extend these results, which may be important for disease
studies where calcium handling properties may also be
affected and coupled with myofibril dysfunction. Impor-
tantly, our approach provides a platform to investigate
the earliest stages of disease development resulting from
alterations in myofibril properties.EXPERIMENTAL PROCEDURES
An expanded version of the Experimental Procedures appears in
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Human Subjects
Protocols for this study were approved by the Institutional Review
Board of the University of Washington. Written consent was ob-
tained from all study participants.
Human Pluripotent Stem Cell Culture and Cardiac
Differentiation
Patient-derived cardiomyocytes were differentiated from two
healthy volunteers, control1 hiPSC line generated from urine and
control2 from skin fibroblasts of healthy patients as well as for
the FCM patient hiPSC lines as previously described (Guan et al.,
2014). The cardiac myocyte differentiation protocol is described
in the Supplemental Experimental Procedures.
Fabrication and Cell Maturation onto a
Nanopatterned Substratum
Anisotropically nanofabricated substrata (ANFS) were fabricated
using a capillary force lithography procedure as previously
described (Kimet al., 2010;Macadangdang et al., 2014). Further de-
tails are given in the Supplemental Experimental Procedures.
Cell Morphology, Myofibril Structural, and Protein
Analysis
Long-term cultured hiPSC-CM onto nanopatterned surfaces were
washed with PBS and in succession fixed with 4% paraformalde-
hyde, and morphological characteristics were assessed by
confocal microscopy. Myofibril structure was assessed by TEM.
Sarcomeric protein composition was studied by SDS-PAGE and
western blot analysis using frozen remains of myofibril prepara-
tions. Details are provided in the Supplement Experimental
Procedures.
Myofibrils
Myofibrils were isolated using two separate approaches. One
approach provided a greater yield so was used for the majority of
experiments. Myofibrils were mounted in a custom-built appa-
ratus, and the mechanical properties measured as previously
described (Colomo et al., 1998; Moussavi-Harami et al., 2015;
Racca et al., 2015; Tesi et al., 1999). Details are provided in the Sup-
plemental Experimental Procedures.
Statistical Analysis
Data are reported as means ± SEM. Student’s two-tailed t test was
used with statistical significance in control- and FCM-hiPSC-CM
lines set at *p < 0.05 and **p < 0.01. For controls comparison,
one-way ANOVA with a Tukey post hoc test was used with statisti-
cal significance set at p < 0.05. The number of independent exper-
iments (N) performed was more than three for each analysis. For
myofibril mechanics analysis, n = number of myofibrils.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, two figures, and one table and can be found with
this article online at http://dx.doi.org/10.1016/j.stemcr.2016.
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